Phreesia price target raised to $31 from $30 at Baird

Baird raised the firm’s price target on Phreesia to $31 from $30 and keeps an Outperform rating on the shares. The firm reported solid results and anticipated client additions going forward are prioritizing “profitable revenue growth,” which should yield improving retention and CAC payback.